299-75-2
299-75-2
Chemical Structure
Treosulfan
Synonym(s): NSC 39069; Treosulphan
- CAS No.: 299-75-2
- Formula:C6H14O8S2
- Molecular Weight:278.30
IUPAC Name: (2S,3S)-2,3-dihydroxybutane-1,4-diyl dimethanesulfonate
InChIKey: YCPOZVAOBBQLRI-WDSKDSINSA-N
SMILES: O[C@H]([C@@H](O)COS(C)(=O)=O)COS(C)(=O)=O
Biological Activity: Treosulfan (NSC 39069) is a bifunctional alkylating agent with activity in ovarian cancer and other solid tumor types.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Treosulfan | 98.0% | Treosulfan (NSC 39069) is a bifunctional alkylating agent with activity in ovarian cancer and other solid tumor types. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ritrosulfan | Ritrosulfan is a member of the alkylating sugar alcohol. Ritrosulfan is a hydrolyzing alkylating agent with anti-tumor activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Yoshi-864 | Yoshi-864 (NSC-102627) is an alkylsulfonate DNA crosslinker with anticancer activity. Yoshi-864 extends markedly the survival times of mice bearing L1210 leukemia or Ehrlich ascites carcinoma. Yoshi-864 also has a persistent reduction in ability to synthesize DNA in tumor cells from mice bearing the Ehrlich tumor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1,6-Bis(mesyloxy)hexane | 16-Bismesyloxyhexane is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PEG4-MS | PEG4-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Undecyl methanesulfonate | Undecyl methanesulfonate is an ester product. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dodecyl methane sulfonate | 99.84% | Dodecyl methane sulfonate is an ester product. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ms-PEG4-MS | 95.0% | Ms-PEG4-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hepsulfam (Standard) | ≥98% | Hepsulfam (NCI 329680; ZINC01574758) is a anticancer agent that shows excellent antileukemic activity with an median IC50 of 0.91 μg/mL in a panel of different tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Galactose-6-O-sulfate sodium salt | 99.95% | D-Galactose-6-O-sulfate sodium salt (D-Galactose-6-O-sulphate sodium salt) is a sulfated derivative of D-Galactose (HY-N0210). D-Galactose-6-O-sulfate sodium salt does not block the binding of ganglioside antibody DG2 to solid-phase sulfatides. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MS-PEG3-O-MS | MS-PEG3-O-MS is a PROTAC linker that can be used in the synthesis of PROTACs. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
